ARTICLE | Clinical News

La Jolla Pharma preclinical data

April 3, 1995 7:00 AM UTC

LJPC (San Diego) presented preclinical data on the tolerization of B cells of the immune system, showing suppression in immunized mice of anti-double-stranded DNA antibodies implicated in the kidney disease.

As reported at the International Conference on Systemic Lupus Erythematosus in Jerusalem, serum levels of the antibodies were lowered by 80 percent, and the antibody-producing cells were also depleted by 80 percent. ...